JPRN-UMIN000005564已完成未知
The efficacy of Carperitide 3-days continuous intravenous injection for the subjects with RAS-inhibitors resistant diabetic nephropathy - Carperitide iv for RASI resistant diabetic nephropathy
Kanazawa University, Graduate School of Internal Medicine, department of internal medicine0 个研究点目标入组 2 人开始时间: 2011年5月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
Canceled due to the insufficient numbers of the cases
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •exclusion criteria are shown as below; subjects with decreased hepatic metabolism including acute hepatitis, exaggerated phase of chronic hepatitis, liver cirrhosis, hepatocellular carcinoma and jaundice, women with pregnancy and its possibility or lactation and subjects whom the attending doctor considered as non-suitable for the entry for this study.
研究者
相似试验
进行中（未招募）
不适用
Selective depletion of C-reactive protein by therapeutic apheresis (CRP-apheresis) in ischemic strokeI63Cerebral infarctionDRKS00021102Pentracor GmbH3
已完成
2 期
Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301)JPRN-UMIN000013019Department of Gastroenterology, Kitasato University School of Medicine6
招募中
不适用
Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndromeambert-Eaton myasthenic syndrome(LEMS)JPRN-UMIN000029085Gunma university graduate school of medicine1
已完成
3 期
Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early versus delayed treatment with venglustat (GZ/SAR402671) in patients at risk of rapidly progressive autosomal dominant polycystic kidney disease (ADPKD)kidney diseaseADPKDNL-OMON51229Genzyme Europe BV32
已完成
1 期
Phase I study on the feasibility of Nedaplatin plus S-1 combination therapy for squamous cell lung cancer.JPRN-UMIN000009993Fukuoka University Hospital18